INOV Inovalon Holdings Inc. Class A

Inovalon Launches Population Health Insights: COVID-19 Compass Dashboard

Inovalon Launches Population Health Insights: COVID-19 Compass Dashboard

Data-Driven Dashboard Provides Health Plans, Employers, and Government Agencies with Expanded Insight into COVID-19 Incidence and Relative Risk within Definable Populations

BOWIE, Md., May 19, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the availability of its new Population Health Insights: COVID-19 Compass Dashboard. This interactive dashboard provides data-driven insights to inform COVID-19 response plans – empowering health plans, providers, employers, and municipalities with actionable intelligence pertaining to geographic areas with a high prevalence of COVID-19 infections and populations most at-risk as they plan strategies around preventative care, re-opening businesses, and managing overall healthcare system needs.

A version of the dashboard is now publicly available at the following URL () to more broadly assist with organizations’ planning and strategic decisions. 

Driven by Inovalon’s , the nation’s largest primary-source dataset comprised of data from more than 315 million patients and 55 billion medical events, the dashboard displays the near real-time prevalence of COVID-19 cases by county across the nation combined with a risk exposure score comprised from analyses of each underlying geographical region’s de-identified patient cohorts known pre-existing disease conditions, demographics details, and social determinants of health (SDOH) in accordance with recommendations from the World Health Organization, the Centers for Disease Control and Prevention, and from other published sources of scientific guidance pertaining to factors of clinical health, demographics, and social determinants of health (SDOH) found to be relevant to COVID-19.

“Many health plans, providers, employers, and municipalities lack the infrastructure and means to integrate data from disparate data sources and provide this level of insight into a population’s relevant underlying disease burden, demographics, and socio-economic factors – all of which are critical pieces for responding effectively to the global pandemic on the respective local stage,” said Mike Burgin, executive vice president of products at Inovalon. “By providing these insights to the public, we can empower health plans, providers, employers, and government officials with another valuable tool in their arsenal to navigate decisions pertaining to re-opening commerce, pinpointing medical facilities and resources that may be most likely stressed, and geographies with individuals most at risk.”

About Inovalon’s Population Health Insights

Inovalon’s COVID-19 Compass Dashboard was built upon Inovalon’s Population Health Insights solution. Inovalon’s Population Health Insights solution includes the following dashboards as well as member-level drill down capabilities:

  • Select Cohorts and Geographies vs. State and National Comparison: Provides a comparison of the prevalence of a selected disease condition within any selected cohort or geography (or set of cohorts and geographies) versus national-level data.
  • Chosen Condition vs. Risk Score: Provides a comparison of the prevalence of a selected disease condition by the average risk score within any selected cohort or geography (or set of cohorts or geographies) versus the overall population.
  • Chosen Condition vs. SDOH: Provides a comparison of the prevalence of a selected disease condition by social determinants of health within any selected cohort or geography (or set of cohorts or geographies) versus the overall population.
  • Chosen Condition vs. Demographics: Provides a comparison of the prevalence of a selected disease condition by demographic factors within any selected cohort or geography (or set of cohort or geographies) and versus the overall population.
  • Chosen Customizable Analytics vs. Any Available Criteria Dimension: Provides a comparison of any custom-requested analytic outcome within any selected cohort or geography (or set of cohorts or geographies) versus any available criteria dimension, such as known and predicted prevalence, patterns, interrelationships, quality, and economics pertaining to patient cohort disease, risk, diagnostics, treatments, outcomes, persistence, costs, and a wide array of additional factors, at patient, provider, facility, geography, and custom cohort levels.

With this comprehensive patient-level view empowered by Inovalon’s Population Health Insights, health plans, providers, and Accountable Care Organizations, have access to both clinical care and non-clinical data to more effectively manage the underlying factors that impact the health of a population. Leveraging this insight, healthcare organizations are well positioned to deploy targeted strategies to proactively address the dynamic needs of their membership to improve quality outcomes and economics.

Inovalon’s broader Population Health Insights solution provides clients with deep, dynamic, real-time insight into the known and predicted prevalence, patterns, interrelationships, quality, and economics pertaining to patient cohort disease, risk, diagnostics, treatments, outcomes, persistence, costs, and a wide array of additional factors, at patient, provider, facility, geography, and custom cohort levels.

About Inovalon

Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million Americans, and 55 billion medical events. For more information, visit .

Contact:

Kim E. Collins

Senior Vice President, Corporate Marketing & Communications



301-809-4000 x1473

Hulus Alpay

Vice President, Investor Relations



301-809-4000 x1237

EN
19/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inovalon Holdings Inc. Class A

 PRESS RELEASE

Equity Consortium Led by Nordic Capital and Including Insight Partners...

Equity Consortium Led by Nordic Capital and Including Insight Partners Completes Acquisition of Inovalon Partnership to Advance Inovalon’s Mission of Empowering Data-Driven Healthcare BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders o...

 PRESS RELEASE

Pharmacy Leaders and Technology Innovators Convene Virtually November ...

Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021 Industry Experts Highlight Strategies for Advancing Data Sharing and Improving Pharmaceutical Patient Care at Inovalon’s ScriptMed® Conference BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry’s leading executives and thought leaders discussing the ways in which techno...

 PRESS RELEASE

Inovalon to Host Virtual Client Congress October 18-19, 2021

Inovalon to Host Virtual Client Congress October 18-19, 2021 Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation’s most influential voices to address the programs, perspectives, an...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2021 08 31

CTSH has built an industry-leading asset-based consulting business over the past 15 years, seeing remarkably stable returns and steady investment in growth, through various economic cycles and potentially impactful regulatory changes. However, the market is expecting both their ability to drive growth and sustain and improve profitability to severely erode going forward, with UAFRS-based (Uniform) ROA falling by half and growth slowing too. While markets are overly pessimistic, management is al...

Valens Research
  • Valens Research

INOV - Embedded Expectations Analysis - 2021 08 30

Inovalon Holdings, Inc. (INOV:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 37.0x Uniform P/E, implying somewhat bullish expectations for the firm. However, although management's concerns about revenue guidance, contract wins, and sales trend disruptions suggest potential short-term headwinds, market expectations are still too pessimistic, and longer-term equity outperformance remains warranted. Specifically, management may lack confidence in ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch